Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1-nitrosourea in colon tumor xenografts.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2003-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 14578471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Base excision repair as a therapeutic target in colon cancer.

  2002cited by this paper
• Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells.

  2002cited by this paper
• Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.

  2001cited by this paper
• Potentiation of BCNU cytotoxicity by molecules targeting abasic lesions in DNA.

  2001cited by this paper
• Base Excision Repair Intermediates as Topoisomerase II Poisons*

  2001cited by this paper
• A public domain image-analysis program for the single-cell gel-electrophoresis (comet) assay.

  2000cited by this paper
• Protection against Methylation-induced Cytotoxicity by DNA Polymerase β-Dependent Long Patch Base Excision Repair*

  2000cited by this paper
• Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.

  1999cited by this paper
• Effect of cations on the formation of DNA alkylation products in DNA reacted with 1-(2-Chloroethyl)-1-nitrosourea.

  1999cited by this paper
• Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions.

  1998cited by this paper
• Apurinic Sites Are Position-specific Topoisomerase II Poisons*

  1997cited by this paper
• Effects of Uracil Incorporation, DNA Mismatches, and Abasic Sites on Cleavage and Religation Activities of Mammalian Topoisomerase I*

  1997cited by this paper
• DNA excision repair pathways.

  1997cited by this paper
• DNA repair in eukaryotes.

  1996cited by this paper
• Repair‐deficient 3‐methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation‐induced chromosome damage and cell killing.

  1996cited by this paper
• DNA repair: enzymatic mechanisms and relevance to drug response.

  1996cited by this paper
• Abasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase II

  1995cited by this paper
• O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.

  1995cited by this paper
• Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.

  1994cited by this paper
• Elevated DNA Polymerase α, DNA Polymerase β, and DNA Topoisomerase II in a Melphalan-resistant Rhabdomyosarcoma Xenograft That Is Cross-Resistant to Nitrosoureas and Topotecan

  1994cited by this paper
• Processing in vitro of an abasic site reacted with methoxyamine: a new assay for the detection of abasic sites formed in vivo.

  1991cited by this paper
• DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal.

  1990cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• In vivo hprt mutant frequencies in T-cells of normal human newborns.

  1990cited by this paper
• Mechanism of action of (2-haloethyl)nitrosoureas on DNA: discrimination between alternative pathways of DNA base modification by 1,3-bis(2-fluoroethyl)-1-nitrosourea by using specific deuterium labeling and identification of reaction products by HPLC/tandem mass spectrometry

  1990cited by this paper
• Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address.

  1989cited by this paper
• Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-N-nitrosourea.

  1988cited by this paper
• Apurinic sites as mutagenic intermediates.

  1985cited by this paper
• A new approach to the study of the base-excision repair pathway using methoxyamine.

  1985cited by this paper
• Apurinic sites as mutagenic intermediates

  1985cited by this paper
• Identification of specific DNA lesions induced by three classes of chloroethylating agents: chloroethylnitrosoureas, chloroethylmethanesulfonates and chloroethylimidazotetrazines.

  1985cited by this paper

• A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1

  2023cites this paper
• Anthracyclines React with Apurinic/Apyrimidinic Sites in DNA.

  2023cites this paper
• DNA Repair Pathways in Cancer Therapy and Resistance

  2021cites this paper
• Chemical Inhibition of Apurinic-Apyrimidinic Endonuclease 1 Redox and DNA Repair Functions Affects the Inflammatory Response via Different but Overlapping Mechanisms

  2021cites this paper
• Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas

  2020cites this paper
• The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites

  2020cites this paper
• Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response

  2020cites this paper
• Method Development and Pharmacological study of Chemotherapeutic Agents

  2017cites this paper
• A Phase 1 Study of TRC 102 , An Inhibitor of Base Excision Repair , and Pemetrexed in Patients with Advanced Solid Tumors

  2017cites this paper
• Chapter 18 DNA Repair and Resistance to Cancer Therapy

  2017cites this paper
• Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine.

  2016cites this paper
• Modulation of human apurinic/apyrimidinic endonuclease 1 (APE1) functions for breast cancer therapy

  2016cites this paper
• A phase 1 trial of TRC102 (methoxyamine HCl) with temozolomide (TMZ) in patients with solid tumors and lymphomas.

  2016cites this paper
• Development Of A Novel Class Of Chemicals For Labeling Abasic Sites In Cellular Dna And Killing Cancer Cells

  2016cites this paper
• Structure‐based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1

  2016cites this paper
• Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells

  2015cites this paper
• Unimolecular Chemically Modified DNA Fluorescent Probe for One-Step Quantitative Measurement of the Activity of Human Apurinic/Apyrimidinic Endonuclease 1 in Biological Samples.

  2015cites this paper
• Covalent Adduct Formation between the Antihypertensive Drug Hydralazine and Abasic Sites in Double- and Single-Stranded DNA

  2014cites this paper
• Elucidating a role for uracil DNA glycosylase (UNG)-initiated DNA base excision repair in the cellular sensitivity to the antifolate, pemetrexed

  2014cites this paper
• Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide

  2013cites this paper
• Targeting DNA Repair Pathways for Cancer Therapy

  2013cites this paper
• Development and characterization of a non-natural nucleoside that displays anticancer activity against solid tumors.

  2013cites this paper
• Differential effects of methoxyamine on doxorubicin cytotoxicity and genotoxicity in MDA-MB-231 human breast cancer cells.

  2013cites this paper
• Cell Death Signaling in Cancer Biology and Treatment

  2013influential citation
• Evidence for base excision repair processing of DNA interstrand crosslinks.

  2013cites this paper
• A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors

  2013cites this paper
• DNA Repair and Resistance to Cancer Therapy

  2013cites this paper
• Developing an in silico model of the modulation of base excision repair using methoxyamine for more targeted cancer therapeutics.

  2013cites this paper
• DNA repair mechanisms protect our genome from carcinogenesis.

  2012cites this paper
• Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

  2012cites this paper
• Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair

  2012cites this paper
• Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.

  2012cites this paper
• In vivo Quantification of Abasic Sites for Efficacious Evaluation of DNA Targeted Chemotherapies

  2012cites this paper
• Effects of solvent, pH and β-cyclodextrin on the fluorescent behaviour of lomustine

  2012cites this paper
• Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT.

  2012cites this paper
• The Identification and Characterization of Human AP Endonuclease-1 Inhibitors

  2012cites this paper
• Development of molecular imaging probes for positron emission tomography

  2012cites this paper
• RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells.

  2011cites this paper
• RECQL 5 is an important determinant for camptothecin tolerance in human colorectal cancer cells

  2011cites this paper
• Immunopotentiation and antitumor effects of a ginsenoside Rg₃-fortified red ginseng preparation in mice bearing H460 lung cancer cells.

  2011cites this paper
• Inhibition of Ape1's DNA Repair Activity as a Target in Cancer: Identification of Novel Small Molecules that have Translational Potential for Molecularly Targeted Cancer Therapy

  2010influential citation
• Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase.

  2010cites this paper
• Conformational transitions in human AP endonuclease 1 and its active site mutant during abasic site repair.

  2010cites this paper
• Distinct Roles of Ape1 Protein in the Repair of DNA Damage Induced by Ionizing Radiation or Bleomycin*

  2010cites this paper
• The Translesion Polymerase Rev3L in the Tolerance of Alkylating Anticancer Drugs

  2009cites this paper
• Going Ape as an Approach to Cancer Therapeutics

  2009cites this paper
• Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair.

  2009cites this paper
• The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme

  2009cites this paper
• Role of APE 1 in differentiated neuroblastoma SH-SY 5 Y cells in response to oxidative stress ; Use of APE 1 small molecule inhibitors to delineate APE 1 functions

  2009cites this paper
• Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions.

  2009cites this paper
• AVALIAÇÃO DA RESPOSTA CELULAR MEDIADA PELO QUIMIOTERÁPICO TEMOZOLOMIDA ASSOCIADA AO INIBIDOR DO REPARO DO DNA METOXIAMINA EM LINHAGENS DE GLIOBLASTOMA

  2009cites this paper
• DNA repair proteins as molecular targets for cancer therapeutics.

  2008cites this paper
• New Insights into Molecular Mechanisms of Fludarabine

  2008cites this paper
• Potent Inhibition of Human Apurinic/Apyrimidinic Endonuclease 1 by Arylstibonic Acids

  2008cites this paper
• DNA Repair Modulators as Anticancer Agents

  2008cites this paper
• Role of the Multifunctional DNA Repair and Redox Signaling Protein Ape1/Ref-1 in Cancer and Endothelial Cells: Small-Molecule Inhibition of the Redox Function of Ape1

  2008cites this paper
• POTENT INHIBITION OF HUMAN AP ENDONUCLEASE 1 BY ARYLSTIBONIC ACIDS

  2007cites this paper
• Combined Treatment with Temozolomide and Methoxyamine: Blocking Apurininc/Pyrimidinic Site Repair Coupled with Targeting Topoisomerase IIα

  2007cites this paper
• Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.

  2007cites this paper
• Theoretical investigation of the decomposition mechanisms of N-(2-chloroethyl)-N-nitrosourea

  2007cites this paper
• Tumor suppression by DNA base excision repair.

  2007cites this paper
• Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence

  2006cites this paper
• Targeted Modulation of MGMT: Clinical Implications

  2006cites this paper
• Rational Design and Development of Targeted Brain Tumor Therapeutics

  2005cites this paper
• Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.

  2005cites this paper
• ASCIZ regulates lesion‐specific Rad51 focus formation and apoptosis after methylating DNA damage

  2005cites this paper
• Improved measurement of dibenzo[a,l]pyrene-induced abasic sites by the aldehyde-reactive probe assay.

  2005cites this paper
• Sensitization of human carcinoma cells to alkylating agents by small interfering RNA suppression of 3-alkyladenine-DNA glycosylase.

  2005cites this paper
• A Simple and Quantitative Method for Analysis of Methoxyamine by Capillary Zone Electrophoresis

  2005cites this paper
• CommentaryDNA Base Excision Repair Defects in Human Pathologies

  2004cites this paper
• Human DNA glycosylases involved in the repair of oxidatively damaged DNA.

  2004cites this paper
• Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.

  2004cites this paper